Recent Updates
Recently added Catalysts
NRXP Positive Sentiment

Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

Thursday, December 5, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Jonathan Javitt, MD, MPH, the Founder and Chief Scientist of NRx Pharmaceuticals, is set to present at the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference. The event will take place on December 3, 2024, at Florida Atlantic University, providing a platform for discussing the company's advancements and future prospects.
Price reaction · baseline $1.19 (2024-12-05 close) · hit after-hours · clean, no other NRXP news in the window
day 0 close · peak
+2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Jonathan Javitt's presentation highlights NRx Pharmaceuticals' growth potential.
  • Participation in a prestigious conference showcases company visibility.
  • Engagement with investors can lead to future funding opportunities.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+167%
120-day peak, hindsight
Typical move
4.3%
average across 2 past catalysts
Cash runway
~12 mo
Low dilution risk
Lead asset
NRX-101
Phase 2 · Bipolar Depression

Full Press Release Details

Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at NobleCon20 – Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Tuesday December 3, 2024

Frequently Asked Questions

What is the NobleCon20 conference?

NobleCon20 is the Twentieth Annual Emerging Growth Equity Conference organized by Noble Capital Markets.

When is Jonathan Javitt's presentation scheduled?

Jonathan Javitt's presentation is scheduled for December 3, 2024.

Who is Jonathan Javitt?

Jonathan Javitt, MD, MPH, is the Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals.

Where will the conference take place?

The conference will be held at Florida Atlantic University.

ShareAdd on Google
Tags: NRXP Viatris Investor Conferences Healthcare Jonathan Javitt Noble Capital Markets Emerging Growth Equity Conference Florida Atlantic University
Last updated: Dec 5, 2024

Biotech snapshot

Cash runway
$27M liquidity · $2M/mo burn
~12 mo
Low dilution risk
Lead asset
NRX-101Phase 2
Bipolar Depression →

Catalyst track record

+167%
best trade around NRXP's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for NRXP.

See every catalyst's timing & PoA →